- Home
- OMC vs ILMN Comparison
OMC vs ILMN Comparison
Compare OMC & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMC
- ILMN
- Stock Information
- Founded
- OMC 1944
- ILMN 1998
- Country
- OMC United States
- ILMN United States
- Employees
- OMC N/A
- ILMN N/A
- Industry
- OMC Advertising
- ILMN Medical Specialities
- Sector
- OMC Consumer Discretionary
- ILMN Health Care
- Exchange
- OMC Nasdaq
- ILMN Nasdaq
- Market Cap
- OMC 16.8B
- ILMN 15.9B
- IPO Year
- OMC N/A
- ILMN 2000
- Fundamental
- Price
- OMC $82.30
- ILMN $94.20
- Analyst Decision
- OMC Buy
- ILMN Buy
- Analyst Count
- OMC 8
- ILMN 18
- Target Price
- OMC $108.25
- ILMN $158.11
- AVG Volume (30 Days)
- OMC 2.6M
- ILMN 3.1M
- Earning Date
- OMC 02-04-2025
- ILMN 02-06-2025
- Dividend Yield
- OMC 3.42%
- ILMN N/A
- EPS Growth
- OMC 7.96
- ILMN N/A
- EPS
- OMC 7.46
- ILMN N/A
- Revenue
- OMC $15,689,100,000.00
- ILMN $4,372,000,000.00
- Revenue This Year
- OMC $4.76
- ILMN $2.36
- Revenue Next Year
- OMC $4.09
- ILMN $6.64
- P/E Ratio
- OMC $11.04
- ILMN N/A
- Revenue Growth
- OMC 6.79
- ILMN N/A
- 52 Week Low
- OMC $80.31
- ILMN $93.50
- 52 Week High
- OMC $107.00
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- OMC 37.49
- ILMN 21.89
- Support Level
- OMC $80.31
- ILMN $99.33
- Resistance Level
- OMC $84.57
- ILMN $105.67
- Average True Range (ATR)
- OMC 1.99
- ILMN 4.94
- MACD
- OMC 0.05
- ILMN -1.77
- Stochastic Oscillator
- OMC 24.24
- ILMN 1.80
About OMC Omnicom Group Inc.
Omnicom is a holding company that owns several advertising agencies and related firms. It provides traditional and digital advertising services that include creative design, market research, data analytics, and ad placement. In addition, Omnicom provides outsourced public relations and other communications services. The firm operates globally, providing services in more than 70 countries; it generates more than one half of its revenue in North America and nearly 30% in Europe.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.